Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the state of protein function prediction: a report on the fourth CAFA challenge.

bioRxiv : the preprint server for biologyĀ·2026
Same author

Multimodal survival analysis of glioblastoma using whole-slide histopathology, gene expression, clinical variables and language-model-derived mutation features.

Scientific reportsĀ·2026
Same author

Optineurin modulates mTORC2/AKT/STAT3 signaling to control MHC class II expression and adaptive immunity against HSV-1.

Cell reportsĀ·2026
Same author

Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions.

Frontiers in digital healthĀ·2025
Same author

A novel decoding strategy for ProteinMPNN to design with less visibility to cytotoxic T-lymphocytes.

Computational and structural biotechnology journalĀ·2025
Same author

Tuning ProteinMPNN to reduce protein visibility via MHC Class I through direct preference optimization.

Protein engineering, design & selection : PEDSĀ·2025

Related Experiment Video

Updated: May 10, 2026

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment
06:32

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment

Published on: August 18, 2023

Multi-pathway feature-level interpretability in MHC-I antigen presentation via concept-based modeling.

Piyush Borole1, Denise Boulanger2, Ajitha Rajan1

  • 1School of Informatics, University of Edinburgh, Edinburgh, EH8 9AB, UK.

Methods (San Diego, Calif.)
|May 8, 2026
PubMed
Summary

We developed MHCCBM, a novel gray-box framework for predicting Major Histocompatibility Complex class I (MHC-I) antigen presentation. This interpretable model enhances trustworthiness in neoantigen discovery and immunotherapy development.

Keywords:
Concept-based modelingImmunoinformaticsInterpretabilityMajor histocompatibility complexMulti-pathway

More Related Videos

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Related Experiment Videos

Last Updated: May 10, 2026

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment
06:32

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment

Published on: August 18, 2023

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Area of Science:

  • Immunology
  • Computational Biology
  • Bioinformatics

Background:

  • Accurate prediction of Major Histocompatibility Complex class I (MHC-I) antigen presentation is crucial for neoantigen discovery and developing immunotherapies.
  • Current deep-learning predictors, while accurate, often function as black boxes, limiting their interpretability and trustworthiness.

Purpose of the Study:

  • To introduce MHCCBM, a gray-box framework designed to decompose MHC-I antigen presentation into interpretable pathway-level concepts.
  • To enhance the trustworthiness of antigen presentation predictors through improved interpretability.

Main Methods:

  • MHCCBM decomposes antigen presentation into distinct modules: proteasomal cleavage, TAP transport, peptide-MHC binding affinity, and chaperone dependency.
  • The framework supports representational multimodality, integrating sequence-based, structure-informed, or empirical predictors.
  • The reference implementation uses ESM-2 for peptide processing and chaperone dependency, MHCflurry for binding affinity, and logistic regression for concept combination.

Main Results:

  • The MHCCBM framework achieves accuracy comparable to state-of-the-art predictors.
  • Provides MHC-I pathway-level interpretability that aligns with established cellular mechanisms.
  • Demonstrates flexibility by allowing substitution of individual predictive modules.

Conclusions:

  • MHCCBM offers a more interpretable and trustworthy alternative to black-box models for MHC-I antigen presentation prediction.
  • The modular design facilitates integration of diverse predictive approaches and enhances understanding of the antigen presentation pathway.
  • This framework holds significant potential for advancing neoantigen discovery and immunotherapy development.